Review article · 2022 · Open access
Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status
Biomedicines, 10(7), 1760 · Published 21 July 2022 · DOI 10.3390/biomedicines10071760
In brief
“Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status” is a 2022 review article by Dorota Koníčková and 8 co-authors, published in Biomedicines. OpenAlex counts 118 citations as of 19 November 2026, which puts it in the top 4% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Biomedicines.
- Citations
- 118
- Most cited in
- 2025 (41)
- Field-weighted impact
- 2.86
- References
- 79
- Authors
- 9
Abstract
The understanding of neurodegenerative diseases, traditionally considered to be well-defined entities with distinguishable clinical phenotypes, has undergone a major shift over the last 20 years. The diagnosis of neurodegenerative diseases primarily requires functional brain imaging techniques or invasive tests such as lumbar puncture to assess cerebrospinal fluid. A new biological approach and research efforts, especially in vivo, have focused on biomarkers indicating underlying proteinopathy in cerebrospinal fluid and blood serum. However, due to the complexity and heterogeneity of neurodegenerative processes within the central nervous system and the large number of overlapping clinical diagnoses, identifying individual proteinopathies is relatively difficult and often not entirely accurate. For this reason, there is an urgent need to develop laboratory methods for identifying specific biomarkers, understand the molecular basis of neurodegenerative disorders and classify the quantifiable and readily available tools that can accelerate efforts to translate the knowledge into disease-modifying therapies that can improve and simplify the areas of differential diagnosis, as well as monitor the disease course with the aim of estimating the prognosis or evaluating the effects of treatment. The aim of this review is to summarize the current knowledge about clinically relevant biomarkers in different neurodegenerative diseases.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Koníčková, D., Menšíková, K., Tučková, L., Hényková, E., Strnad, M., Friedecký, D., Stejskal, D., Matěj, R., & Kaňovský, P. (2022). Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status. Biomedicines, 10(7), 1760. https://doi.org/10.3390/biomedicines10071760
MLA 9
Koníčková, Dorota, et al. “Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status.” Biomedicines, vol. 10, no. 7, 2022, p. 1760. https://doi.org/10.3390/biomedicines10071760.
Chicago
Koníčková, Dorota, Kateřina Menšíková, Lucie Tučková, Eva Hényková, Miroslav Strnad, David Friedecký, David Stejskal, Radoslav Matěj, and Petr Kaňovský. 2022. “Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status.” Biomedicines 10 (7): 1760. https://doi.org/10.3390/biomedicines10071760.
Harvard
Koníčková, D. et al. (2022) ‘Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status’, Biomedicines, 10(7), p. 1760. doi:10.3390/biomedicines10071760.
IEEE
D. Koníčková et al., “Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status,” Biomedicines, vol. 10, no. 7, p. 1760, 2022, doi: 10.3390/biomedicines10071760.
BibTeX
@article{konickova2022biomarkers,
title = {{Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status}},
author = {Koníčková, Dorota and Menšíková, Kateřina and Tučková, Lucie and Hényková, Eva and Strnad, Miroslav and Friedecký, David and Stejskal, David and Matěj, Radoslav and Kaňovský, Petr},
journal = {Biomedicines},
year = {2022},
volume = {10},
number = {7},
pages = {1760},
doi = {10.3390/biomedicines10071760},
url = {https://doi.org/10.3390/biomedicines10071760}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 5 | |
| 2023 | 20 | |
| 2024 | 28 | |
| 2025 | 41 | |
| 2026 | 23 |
Its field-weighted citation impact is 2.86: it has been cited 2.86 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- neurodegenerative diseases
- biomarkers
- proteinopathies
- cerebrospinal fluid
- serum biomarkers
- differential diagnosis
- disease-modifying therapy
- disease progression monitoring
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Koníčková, D., Menšíková, K., Tučková, L., Hényková, E., Strnad, M., Friedecký, D., Stejskal, D., Matěj, R., & Kaňovský, P. (2022). Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status. Biomedicines, 10(7), 1760. https://doi.org/10.3390/biomedicines10071760
How many times has this paper been cited?
118 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Biomedicines: sign in and open the PDF from this page.
Who wrote this paper?
Dorota Koníčková, Kateřina Menšíková, Lucie Tučková, Eva Hényková, Miroslav Strnad, David Friedecký, David Stejskal, Radoslav Matěj, Petr Kaňovský.
What is the DOI of this paper?
10.3390/biomedicines10071760, permanently at https://doi.org/10.3390/biomedicines10071760. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.